Oliver Houtved

Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe.

Oxbridge NV offers modern business premises for sale or rent in Hoevenen, BE. The Belgian company provides a detached building with contemporary offices and a spacious workshop/warehouse on a laid-out site. The offices have plenty of natural light, and there is a separate loskade paving for heavy traffic. The premises include a meeting room with a projector, a kitchen, and toilet blocks for men and women. Additionally, there is a server room with a secure door and a private entry with an adhesion column.

DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark

Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark.

Nykredit Bank A/S (Investment Management) (Nykredit IM) is the investment management division of Nykredit Bank A/S, ultimately held by Forengin Nykredit in Denmark. The firm was founded in 1851 and changed their name to Nykredit in 1985 when Forenede Kreditforeninger and Jyllands Kreditforening merged. Nykredit IM is headquartered in Copenhagen and provides securities management, deposit and loan products, financial instruments and asset management services for individual, corporate and commercial clients.

Skandinaviska Enskilda Banken AB (Broker) (SEB-Broker) is the broker/dealer division of Skandinaviska Enskilda Banken AB (STO: SEB-A; OTCMKTS: SVKEF), a financial group headquartered in Stockholm, Sweden. Founded in 1856, SEB-Broker provides trading and executions services to their clients.

Nordea Kredit Realkredit A/S provides mortgage services. It offers all types of mortgage credit activities such as mortgage loans. The company was founded on January 9, 1991 and is headquartered in Taastrup, Denmark.

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.

Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden.

Social Starts LLC (Social Starts) is a Venture Capital firm is founded in 2012. The firm is headquartered in San Francisco, New York.

Joyance Partners is a venture capital firm founded in 2017. The firm is headquartered in San Francisco, California.

Falcon Fondsmæglerselskab A/S is a Danish company founded in 2015 and headquartered in Aarhus, Denmark. The company specializes in the academically recognized momentum strategy and offers publicly traded funds with fair and transparent terms. The company's expertise in this strategy allows investors to make informed decisions. The CEO is Thomas Knudsen.

Part of Nordea Bank Abp, Nordea Bank Abp (Commissioned Research Denmark) is a Danish financial company that offers a new digital platform called Nordea Corporate. The company is based in Copenhagen, Denmark. The platform aims to simplify financial management for financial professionals in corporates. Anders Holkmann Olsen has been the CEO of the company since 2013.

Fondsmæglerselskabet SRV Capital A/S is a Danish investment firm based in Charlottenlund, Denmark. The company specializes in fixed income investment products that aim to deliver a return above the Danish central bank's repo rate while adding diversification to most investment portfolios. The private company's team possesses over 50 years of experience in the Scandinavian fixed income markets and knows how to act in all types of market conditions, including distressed markets. The company was founded in 2018 by Torben Pedersen and Erik Bo Hansen, with Erik Bo Hansen serving as the CEO since then.